MiR‐2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting JAG2. (11th May 2022)

• Record Type: Journal Article
• Authors: Sun, Bin; Ji, Weidan; Liu, Chunying; Lin, Xuejing; Chen, Lei; Qian, Haihua; Su, Changqing
• Is Part Of: Liver international. Volume 42:Number 7(2022)
• Page Start: 1658
• Page End: 1673
• Publication Date: 2022-05-11
• Subjects: hepatocellular carcinoma -- JAG2 -- metastasis -- microRNA -- proliferation -- tumour suppressor; Liver -- Periodicals; Liver -- Diseases -- Periodicals; 616.362
• DOI: 10.1111/liv.15284
• Languages: English
• ISSNs: 1478-3223

Abstract

Abstract: Background & Aims: Dysregulation of microRNA (miRNA) expression in various cancers and their vital roles in malignant progression of cancers are well investigated. Our previous studies have analysed miRNAs that promote malignant progression in hepatocellular carcinoma (HCC); this study aims to systematically elucidate the mechanism of metastasis suppressor miRNAs in HCC. Methods: High‐throughput RNA sequencing was used to identify anti‐metastatic miRNAs. The relative expression levels of miRNAs were confirmed by qRT‐PCR. The biological functions of miRNAs were detected in vitro and in vivo. Circulating tumour cells (CTCs) were enriched from blood samples of HCC patients and cultured by three‐dimensional (3D) system. Kaplan–Meier and Cox regression were used to analyse the value of potential target mRNAs on overall survival. Results: miR‐2392 was significantly down‐regulated in HCC. Overexpression of miR‐2392 suppressed proliferation, clonogenicity, mobility, spheroid formation and maintenance of cancer stem cells (CSC)‐like characteristics in HCC cells. CTCs from HCC patients with lower serum miR‐2392 level had stronger cell spheroid formation ability. A negative correlation between the content of miR‐2392 in serum and the number of CTC spheroids had been found. We identified Jagged2 (JAG2) as a direct target of miR‐2392. miR‐2392 inhibited the expression of JAG2 by targeting 3'‐UTR of JAG2. Down‐regulation of JAG2 inhibited the overexpression effects of miR‐2392 in vitro and in vivo. JAG2 is highly expressed in HCC and is closely related to poor prognosis and survival of patients. Conclusions: miR‐2392 may play a role as a tumour suppressor to guide the individualized precise treatment of HCC.